Ranitidine

Ranitidine是组胺H2-受体拮抗剂，IC50为3.3±1.4 μM。A histamine H2-receptor antagonist.

Ranitidine是组胺H2-受体拮抗剂，IC50为3.3±1.4 μM。A histamine H2-receptor antagonist.

Ranitidine是组胺H2-受体拮抗剂，IC50为3.3±1.4 μM。A histamine H2-receptor antagonist.

Ranitidine是组胺H2-受体拮抗剂，IC50为3.3±1.4 μM。A histamine H2-receptor antagonist.

4-(Piperazin-1-yl)pyrimidine.

4-(Piperazin-1-yl)pyrimidine.

InformationGimeracil Gimeracil is an inhibitor of dihydropyrimidine dehydrogenase, which inhibits the early step in homologous recombination for double strand breaks

(±)-Zanubrutinib ((±)-BGB-3111) is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor.In VitroIn both biochemical and cellular assays, (±)-Zanubrutinib ((±)-BGB-3111) demonstrates nanomolar Btk inhibition activity. In

(±)-Zanubrutinib ((±)-BGB-3111) is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor.In VitroIn both biochemical and cellular assays, (±)-Zanubrutinib ((±)-BGB-3111) demonstrates nanomolar Btk inhibition activity. In

(±)-Zanubrutinib ((±)-BGB-3111) is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor.In VitroIn both biochemical and cellular assays, (±)-Zanubrutinib ((±)-BGB-3111) demonstrates nanomolar Btk inhibition activity. In

(±)-Zanubrutinib ((±)-BGB-3111) is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor.In VitroIn both biochemical and cellular assays, (±)-Zanubrutinib ((±)-BGB-3111) demonstrates nanomolar Btk inhibition activity. In

ranimycin.